Another scumbag pharma CEO - Gouges Epipen users and salary raised to $18.9 million

Heather Bresch should get the same treatment as Martin Shkreli.

For those with severe allergies, the EpiPen is literally a matter of life or death. A bee sting, inadvertent peanut ingestion—these can lead to anaphylactic shock, which shuts down the airways and can ultimately lead to death. With a quick stab to the thigh, though, the EpiPen can avoid tragedy by dispensing epinephrine. Epinephrine reverses the closing of the airways and other symptoms of a severe allergic reaction.

There’s just one problem: The EpiPen is becoming unaffordable.

In 2007, the cost of a two-pen set of the EpiPen, which contains about $1 worth of epinephrine in it, cost about $57. Then pharmaceutical company Mylan acquired it. The price has since undergone a 400 percent price increase, with the biggest changes in price coming in the past few years. In 2013, the price was $264.50. In May of 2015, it was $461. This May, the company again raised the cost to $608.61.

http://secondnexus.com/social-commentary-and-trends/heather-bresch-gouged-epipen/?utm_content=inf_10_1164_2&tse_id=INF_fda5a9f069f711e6aea2d77665e8622b